Development of novel SRC tyrosine kinase inhibitors for the treatment of osteoporosis.

被引：0
|
作者：
Naugle, JL [1 ]
Wang, YH [1 ]
机构：
[1] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
369-MEDI
引用
收藏
页码：U71 / U72
页数：2
相关论文
共 50 条
  • [21] HIV protease inhibitors cause osteoporosis.
    Wang, MWH
    Teitelbaum, SL
    Tebas, P
    Yarasbeski, KE
    Powderly, WG
    Wei, S
    Ross, FP
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S503 - S503
  • [22] ADHERENCE TO TREATMENT WITH TYROSINE KINASE INHIBITORS
    Feliu Amanda, Perez
    Jose Luis, Marco Garbayo
    Segura Pilar, Blasco
    Castello Isabel, Perez
    Barber Eduardo, Peiro
    ATENCION FARMACEUTICA, 2013, 15 (06): : 390 - +
  • [23] Tyrosine kinase inhibitors in sarcoma treatment
    Kyriazoglou, Anastasios
    Gkaralea, Lydia Evangelia
    Kotsantis, Ioannis
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Prevezanou, Maria
    Chatzidakis, Ioannis
    Kavourakis, Georgios
    Economopoulou, Panagiota
    Nixon, Ioanna Fragkandrea
    Psyrri, Amanda
    ONCOLOGY LETTERS, 2022, 23 (06)
  • [24] MEDI 105-Novel purine derivatives as potent dual Src/Abl tyrosine kinase inhibitors
    Wang, Yihan
    Shakespeare, William C.
    Huang, Wei-sheng
    Sundaramoorthi, Raji
    Lentini, Scott
    Das, Sasmita
    Liu, Shuangying
    Banda, Geeta
    Wen, David
    Zhu, Xiaotian
    Xu, Qihong
    Keats, Jeff
    Wang, Frank
    Wardwell, Scott
    Ning, Yaoyu
    Snodgrass, Joseph T.
    Broudy, Mark I.
    Russian, Karin
    Iulucci, John
    Dalgarno, David
    Clackson, Tim
    Sawyer, Tomi K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [25] Synthesis, ADMET and Docking Studies of Novel Pyrazoles Incorporating Coumarin Moiety as Tyrosine Kinase (Src) Inhibitors
    Aqlan, Faisal M.
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2021, 11 (05): : 13706 - 13714
  • [26] Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors
    Wang, Yihan
    Shakespeare, William C.
    Huang, Wei-Sheng
    Sundaramoorthi, Raji
    Lentini, Scott
    Das, Sasmita
    Liu, Shuangying
    Banda, Geeta
    Wen, David
    Zhu, Xiaotian
    Xu, Qihong
    Keats, Jeffrey
    Wang, Frank
    Wardwell, Scott
    Ning, Yaoyu
    Snodgrass, Joseph T.
    Broudy, Mark I.
    Russian, Karin
    Dalgarno, David
    Clackson, Tim
    Sawyer, Tomi K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4907 - 4912
  • [27] Design and synthesis of peptide analogs as inhibitors of SRC tyrosine kinase.
    Pitts, RL
    Parang, K
    Sun, GQ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U25 - U25
  • [28] TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF LEUKEMIA - PROBLEMS ON THE DEVELOPMENT AND CLINICAL USE -
    Kiyoi, Hitoshi
    ANNALS OF ONCOLOGY, 2010, 21 : 9 - 9
  • [29] Exploitation of the 3-quinolinecarbonitrile template for Src tyrosine kinase inhibitors
    Boschelli, Diane H.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (10) : 922 - 934
  • [30] Conformationally constrained peptide analogs of CIYKYY as inhibitors of Src tyrosine kinase
    Ye, Guofeng
    Kumar, Anil
    Wang, Yuehao
    Sun, Gongqin
    Parang, Keykavous
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2730 - U2730
12345